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Summary
Objective: The objective of this study is to systematically assess the quality of
existing patient-reported outcome measures developed and/or validated for Quality
of Life measurement in bariatric surgery (BS) and body contouring surgery (BCS).
Methods: We conducted a systematic literature search in PubMed, EMBASE,
PsycINFO, CINAHL, Cochrane Database Systematic Reviews and CENTRAL
identifying studies on measurement properties of BS and BCS Quality of Life instru-
ments. For all eligible studies, we evaluated the methodological quality of the stud-
ies by using the COnsensus-based Standards for the selection of health
Measurement INstruments checklist and the quality of the measurement instru-
ments by applying quality criteria. Four degrees of recommendation were assigned
to validated instruments (A–D).
Results: Out of 4,354 articles, a total of 26 articles describing 24 instruments
were included. No instrument met all requirements (category A). Seven instruments
have the potential to be recommended depending on further validation studies
(category B). Of these seven, the BODY-Q has the strongest evidence for content
validity in BS and BCS. Two instruments had poor quality in at least one required
quality criterion (category C). Fifteen instruments were minimally validated
(category D).
Conclusion: The BODY-Q, developed for BS and BCS, possessed the strongest
evidence for quality of measurement properties and has the potential to be recom-
mended in future clinical trials.
Keywords: Bariatric surgery, body contouring surgery, PRO measurement, quality
of Life.
Abbreviations: BCS, body contouring surgery; BS, bariatric surgery; BQL-Index,
Bariatric Quality of Life Index; COS, Core Outcome Set; COSMIN, COnsensus-
based Standards for the selection of health Measurement INstruments; GIQLI, Gas-
trointestinal Quality of Life Index; HRQoL, Health Related Quality of Life;
IWQoL-Lite, Impact of Weight Quality of Life-Lite; M-A QoLQ, Moorehead-
Ardelt Quality of Life Questionnaire; M-A QoLQII, Moorehead-Ardelt Quality
of Life Questionnaire II; OP-scale, Obesity-related Problems scale; PRO, Patient-re-
ported outcome; PROMs, patient-reported outcome measures; QoL, Quality of
Life; RMT, Rasch Measurement Theory.
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Introduction
The prevalence of severe and complex obesity is worsening
in most parts of the world (1). One effective treatment is
bariatric surgery (BS), and this is a rapidly growing area
(2). Evaluating surgery including assessment of patients’
views is important (3). Quality of Life (QoL) is a key out-
come that should be reported in all clinical effectiveness tri-
als in BS (4,5). Indeed, a recently developed Core Outcome
Set (COS) for BS identified QOL as one of the nine items in-
cluded in the final COS and therefore assessed in clinical tri-
als in this area (4). The World Health Organization defined
QoL as an individual’s perception of their position in life in
the context of the culture and value systems in which they
live and in relation to their goals, expectations, standards
and concerns. QoL data offer a reliable assessment of the
patients’ perspectives of BS outcomes and can be useful in
decision-making.
Bariatric surgery generates significant improvements in
some aspects of QoL, particularly in physical domains (6).
The substantial weight loss following BS, however, leaves
many patients with other issues, such as excess skin, which
can have a negative impact on other domains of QoL (e.g.
body image, physical and sexual functioning). Subsequent
body contouring surgery (BCS) has considerable potential
to restore QoL (7–9). Therefore, the growth of BS has been
paralleled with increasing numbers of post-bariatric body
contouring procedures (10). Patient-reported outcome
(PRO) measurement of QoL is highly desirable in post-
bariatric BCS but is not yet routinely captured in (post-)bar-
iatric outcome measurement. Given the growing field of
BCS, the need to understand QoL and cosmetic issues re-
lated to surgical outcomes over the entire weight loss jour-
ney is important and requires information about the most
appropriate PRO measurement instrument for this purpose.
A limitation in the pursuit of such evidence is the lack of
standardization of the measurement of QoL and instru-
ments available to assess it. The wide variety of generic
and disease-specific questionnaires has made meta-analyses
and interpretation across studies difficult (11–14). This
makes it difficult to decide what treatments are best as per-
ceived by the patient and, hence, hampers evidence-based
clinical decision making. To address the lack of standard-
ized PRO measurement instruments (PROMs) in both bar-
iatric and post-bariatric BCS, recommendations about the
most appropriate measurement instrument(s) of QoL
should be made based on quality standards and criteria. In
this systematic review, we aim to provide validation evi-
dence about the most appropriate PROMs of QoL in bariat-
ric and post-bariatric BCS. The COnsensus-based Standards
for the selection of health Measurement INstruments
(COSMIN) methodology was used as guidance to assess
and provide recommendations on the most appropriate
measurement instrument(s) (15). This review is a
continuation of a project to develop a COS for bariatric
and metabolic surgery clinical trials (4).
Material and methods
The Preferred Reporting Items for Systematic Reviews and
Meta-Analyses statement was used as a guidance for
reporting this systematic review (16). This review has been
registered in the International Prospective Register of Sys-
tematic Reviews: CRD42017059783.
Eligibility criteria
Studies were selected if published as full-text papers and if
their purpose was the development (‘development paper’)
and/or evaluation (‘validation paper’) of the measurement
properties of instruments that measure QoL in BS and/or
BCS patients. Studies that reported indirect evidence, such
as clinical trials measuring QoL, were not considered eligi-
ble. Eligible instruments included all PROMs that are specif-
ically designed and/or validated to measure QoL in BS and/or
BCS patients. Articles were excluded if (i) a different con-
struct than QoL was measured, (ii) PROMs were developed
for children or adolescents (age < 18 years) that underwent
BS, and (iii) PROMs were solely developed to measure the
QoL of patients with obesity not related to BS or BCS.
Literature search
On 25 January 2017, we conducted a systematic literature
search in PubMed, EMBASE, Ebsco/PsycINFO,
Ebsco/CINAHL, Cochrane Database Systematic Reviews
and CENTRAL identifying studies on measurement proper-
ties of PROMs of QoL or Health-Related Quality of Life
(HRQoL) in BS and BCS patients. We interpreted QoL
and HRQoL interchangeably. We involved a clinical librar-
ian to optimize the search strategy. The main search strategy
consisted of four blocks of search terms: (i) target popula-
tion (BS and BCS patients); (ii) construct of interest (QoL);
(iii) type of instrument; and (iv) measurement properties.
The search filter Patient Reported Outcomes Measures
(PROMs), developed by Oxford University and available
through the COSMIN website (www.cosmin.nl) and a
highly sensitive search filter for finding studies on properties
of measurement instruments (17), were used for these pur-
poses. We did not limit our search to year of publication,
study design or language. The entire search can be found
in Data S1. The search results were handled within Refer-
ence Manager. The reference lists of included studies were
hand searched for additional articles. We searched the
Patient-Reported Outcome and Quality of Life Instruments
Database database (http://www.proqolid.org) for additional
information.
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Study selection and data extraction
Two reviewers (C. V. and M. K.) independently screened ti-
tles and abstracts and, at a second stage, assessed the full-
text articles retrieved by the literature search to identify
studies evaluating measurement properties. Conflicts were
resolved by consensus of the two reviewers and, if necessary,
a third reviewer (C. P.). For all eligible studies, the same two
independent reviewers (C. V. and M. K.) extracted data
from the selected studies. Data extracted included the char-
acteristics of included studies and instruments, and results
on measurement properties. Evidence tables were used to
summarize data.
Evaluation of the methodological quality of studies
on measurement properties
The COSMIN study developed a consensus-based checklist
to evaluate the methodological quality of studies on mea-
surement properties (15). The COSMIN checklist describes
standards for design requirements and preferred statistical
methods. We evaluated the methodological quality of stud-
ies on their measurement properties using the COSMIN
checklist. The COSMIN taxonomy was used to select which
measurement properties of an instrument were evaluated
(18). According to the COSMIN taxonomy, three domains
can be distinguished: reliability, validity and responsiveness
(18). The measurement properties internal consistency, reli-
ability and measurement error fall within the domain valid-
ity, the measurement properties content validity, construct
validity and criterion validity fall within the domain validity
and the measurement property responsiveness falls within
the domain responsiveness. We assessed internal consis-
tency, reliability, measurement error, content validity (in-
cluding face validity), structural validity, hypotheses testing
(i.e. for convergent and divergent validity) and cross-
cultural validity (these three are aspects of construct valid-
ity), criterion validity and responsiveness. As, in general,
there is no gold standard for PROMs, ‘criterion validity’
was not considered. Each measurement property can be
rated as excellent, good, fair or poor (19). The ‘lowest score
counts’ principle was used, which means that the overall
rating for the study was determined by the lowest rated
measurement property.
The same two reviewers (C. V. and M. K.) independently
evaluated the methodological quality of included studies.
Discrepancies were discussed with a third reviewer (C. P.)
to reach consensus. For the measurement property ‘hypoth-
esis testing’, we evaluated convergent/divergent validity and
discriminative validity. Convergent/divergent validity is the
correlation between a comparator instrument that measures
a similar or different construct. Discriminative validity is the
ability of a measurement instrument to make a distinction
between different subgroups. Data on the interpretability
and generalizability were collected when data were avail-
able. Interpretability and generalizability do not refer to
the quality of an instrument and are therefore not measure-
ment properties. These characteristics are included in the
COSMIN checklist, as they provide important information
on the suitability of a measurement instrument. Interpret-
ability describes whether it is clear what the scores or
change scores of the instrument of interest mean. Interpret-
ability includes an assessment of the distribution of scores,
floor and ceiling effects (the percentage of patients with
the lowest or highest scores; e.g. a high percentage of pa-
tients with the highest scores [ceiling effect] limits the ability
to measure changes) and minimal clinically important dif-
ference (the smallest difference in construct [QoL scores] be-
tween patients that is considered clinically important).
Generalizability describes whether the patient population
in which the measurement instrument was evaluated was
adequately described to generalize the results. We evaluated
different language versions of QoL measurement instru-
ments as distinct instruments. We assumed that different
language versions possess different measurement properties.
Quality of the measurement properties
We independently evaluated the quality of the measurement
properties of the included measurement instruments by ap-
plying the Terwee criteria for good measurement proper-
ties (20) onwhich international consensuswas obtained (21)
(Table 1) (22). The quality of each measurement property
was rated as positive (+), negative () or indeterminate (?).
Quality of the instruments: best evidence synthesis
Taking both the quality of the studies and the quality of the
measurement instruments into account, the overall evidence
on a measurement property includes the number and the
methodological quality of the included studies and the con-
sistency of their results. The overall rating of the quality of a
measurement property was based on a levels of evidence ap-
proach (23). The results of studies of poor methodological
quality were not included in the best evidence synthesis.
The criteria of best evidence synthesis are shown in
Table 2.
Recommendations for the selection of the most
suitable Quality of Life measurement instruments
Recommendations on the most suitable QoL instruments
were based on the methodological quality of included stud-
ies and on the adequacy of the instrument. As previously de-
scribed by the Harmonizing Outcome Measures for Eczema
initiative, the three criteria of the Outcome Measures in
Rheumatology filter had to be met by a measurement instru-
ment to be recommended for use. Outcome measures
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should adequately meet the criteria of (i) truth (i.e. face,
content, construct and criterion validity; measure what it
is intended to measure), (ii) discrimination (i.e. reliability
and sensitivity to change; discriminate between situations
of interest) and (iii) feasibility (i.e. be applied and
interpreted easily) in order to be meaningful and relevant
(24). Four degrees of recommendation were assigned to val-
idated instruments included in this review (A–D), adopted
from the Harmonizing Outcome Measures for Eczema ini-
tiative and applied in previous reviews of this initiative (25):
Table 1 Quality criteria for measurement properties adapted from Terwee et al. (20) and PROMIS Methodology (22)
Property Rating Adequacy criteria
Reliability
Internal consistency
(CTT methods applied)
+ Cronbach’s alpha(s) ≥ 0.70
? Cronbach’s alpha not determined
 Cronbach’s alpha(s) < 0.70
Internal consistency
(IRT methods applied)
+ Person separation index ≥ 0.70
? Person separation index not determined
 Person separation index < 0.70
Measurement error + MIC > SDC OR MIC outside the LoA
? MIC not defined
 MIC ≤ SDC OR MIC equals or inside LoA
Reliability + ICC/weighted Kappa ≥ 0.70, OR Pearson’s r ≥ 0.80
? Neither ICC/weighted Kappa nor Pearson’s r determined
 ICC/weighted Kappa < 0.70 OR Pearson’s r < 0.80
Validity
Content validity + All items are considered to be relevant for the construct to be measured, for the target population and for the
purpose of the measurement AND the questionnaire is considered to be comprehensive
? Not enough information available
 Not all items are considered to be relevant for the construct to be measured, for the target population and for the
purpose of the measurement OR the questionnaire is considered not to be comprehensive
Construct validity
Structural validity
(CTT methods applied)
+ Factors should explain at least 50% of the variance
? Explained variance not mentioned
 Factors explain <50% of the variance
Structural validity
(IRT methods applied)
+ Residual correlations among the items after controlling for the dominant factor < 0.20 OR Q3’s < 0.37, item
scalability > 0.30, IRT model fit: G2 > 0.01, no DIF for important subject characteristics (such as age, gender
and education): McFadden’s R2 < 0.02, OR no non-uniform DIF
? Important statistics not reported
 Residual correlations among the items after controlling for the dominant factor ≥ 0.20 OR Q3’s ≥ 0.37, item
scalability ≤ 0.30, IRT model fit: G2 ≤ 0.01, important DIF for important subject characteristics (such as age,
gender and education): McFadden’s R2 ≥ 0.02, OR non-uniform DIF
Hypothesis testing
(convergent/divergent validity)
+ Correlations with instruments measuring the same construct ≥ 0.50 OR at least 75% of the results are in
accordance with the hypotheses AND correlation with related constructs is higher than with unrelated constructs
? Solely correlations determined with unrelated constructs
 Correlations with instruments measuring the same construct <0.50 OR <75% of the results are in accordance
with the hypotheses OR correlation with related constructs is lower than with unrelated constructs
Hypothesis testing
(discriminative validity)
+ Differences in scores on the measurement instrument for all evaluated patient subgroups are statistically
significant OR ≥75% of results in accordance with hypotheses
? Some differences statistically significant, others not
 Differences in scores on the measurement instrument for all evaluated patient subgroups are not statistically
significant OR <75% of results in accordance with hypotheses
Cross-cultural validity + No differences in factor structure OR no important DIF between language versions
? Multiple group factor analysis not applied AND DIF not assessed
 Differences in factor structure OR important DIF between language versions
Responsiveness
Responsiveness + Correlation with changes on instruments measuring the same construct ≥0.50 OR at least 75% of the results are
in accordance with the hypotheses OR AUC ≥ 0.70 AND correlations with changes in related constructs are
higher than with unrelated constructs
? Solely correlations determined with unrelated constructs
 Correlations with changes on instruments measuring the same construct <0.50 OR <75% of the results are in
accordance with the hypotheses OR AUC < 0.70 OR correlations with changes in related constructs are lower
than with unrelated constructs
AUC, area under the curve; CTT, classical test theory; DIF, differential item functioning; ICC, intraclass correlation coefficient; LoA, limits of agreement;
MIC, minimal important change; SDC, smallest detectable change; +, positive rating; ?, indeterminate rating; , negative rating.
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A. QoL measurement instrument meets all requirements
and is recommended for use.
B. QoL measurement instrument meets two or more
quality criteria, but performance in all other required
quality criteria is unclear, so that the PRO measure-
ment instrument has the potential to be recom-
mended in the future depending on the results of
further validation studies.
C. QoL measurement instrument has low quality in at
least one required quality criterion (≥1 rating of ‘mi-
nus’) and therefore is not recommended for usage.
D. QoL measurement instrument has (almost) not been
validated. Its performance in all or most relevant
quality criteria is unclear, so it is not recommended
to be used until further validation studies clarify its
quality.
Results
Out of the 4,354 articles, 26 articles described development
and validation of a measurement instrument and were con-
sidered eligible for assessment of the methodological quality
(Data S2). These described 24 measurement instruments in
26 studies. Of the measurement instruments included, 21
were developed for BS patients, two for both BS and BCS
patients and one for BCS patients. The characteristics of
the different instruments are displayed in Table 3. Important
characteristics of the included development and validation
studies are shown in Table 4. Information on the content
(i.e. on domain level) of the different instruments is shown
in Table 5. Social functioning was captured in all measure-
ment instruments except the EQ-5D-5L, physical function-
ing was included in all instruments except the bariatric
and obesity-specific survey and sexual functioning was in-
cluded in all instruments except the Bariatric Quality of Life
Index (BQL-Index), the Quality of Life for Obesity Surgery,
the EQ-5D-5L and the Gastrointestinal Quality of Life
Index (GIQLI). Data S3 shows the detailed results of inter-
pretability of the QoL measurement instruments. Values
for the minimal clinically important difference were only
available for the Laval Questionnaire and the EQ-5D-5L.
The BQL-Index, the BODY-Q, the Spanish Obesity-related
Problems scale (OP-scale), the Greek Moorehead-Ardelt
Quality of Life Questionnaire II (M-A QoLQII) and the
Portugese M-A QoLQII showed no evidence for floor or
ceiling effects. The EQ-5D-5L demonstrated ceiling effects
and the Danish BODY-Q demonstrated ceiling effects in
the experience scales.
Quality assessment and results of the studies
The methodological quality of the included studies is pre-
sented in Table 6, and the quality assessment of the mea-
surement properties is presented in Table 7. Data S4
describes detailed results of the different measurement prop-
erties of every single instrument and study.
Quality of the instruments: best evidence synthesis
The results of the best evidence synthesis and recommenda-
tions of QoL instruments (Table 8) are described in the
succeeding texts according to the category of recommenda-
tion (A–D) (Table 9):
Category A instruments
No instrument met all required quality criteria to be recom-
mended for the measurement of QoL in BS and/or BCS.
Category B instruments
Seven measurement instruments have the potential to be
recommended for BS and/or BCS in the future depending
on further validation studies.
Body-Shape-RelatedQuality of Life (body contouring
surgery). The measurement properties of the Body-Shape-
Related Quality of Life were evaluated in two studies. Strong
evidence was found for good content validity (27), moderate
evidence for good internal consistency, limited evidence for
good reliability and moderate evidence for indeterminate
structural validity and hypotheses testing (26). The
evidence for responsiveness remained unclear due to poor
methodological quality of the study (26). For
interpretability, the mean absolute change in score from
baseline was 21.9 (SD 16.9) (26).
Table 2 Levels of evidence for the overall adequacy of a measurement property adapted from Schellingerhout et al. (23)
Level Rating Criteria
Strong +++, ? (strong) or  Consistent findings in multiple studies of good methodological quality OR in one study of
excellent methodological quality
Moderate ++, ? (moderate) or  Consistent findings in multiple studies of fair methodological quality OR in one study of good
methodological quality
Limited +, ? (limited) or  One study of fair methodological quality
Conflicting +/ Conflicting findings
Unknown ? Only studies of poor methodological quality
+, positive rating; ?, indeterminate rating; , negative rating.
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BODY-Q (bariatric surgery and body contouring
surgery). Two studies evaluated the measurement
properties of the BODY-Q. There was strong evidence for
good content validity (28), moderate evidence for good
internal consistency and structural validity, limited
evidence for good reliability and moderate evidence for
indeterminate hypotheses testing (29). The evidence for
responsiveness remains unknown because of poor
methodological quality of the study (29). Interpretability
yielded a mean absolute change ranging from 0.2 (SD
18.7) to 12.4 (SD 19.6) for appearance scales, from 0.5
(SD 17.0) to 9.9 (SD 19.4) for HRQoL scales and from
2.0 (SD 18.8) to 6.0 (SD 16.3) for experience scales
(29). Participants improved on BODY-Q scales following
BS measuring appearance (of abdomen, back, body,
buttocks, hips/outer thighs, inner thigh), body image and
physical function and social function (moderate to large
effect sizes [0.60 to 2.29] and standardized response
means [0.47 to 1.35]) (30).
Bariatric and obesity-specific survey (bariatric
surgery). The measurement properties of the bariatric
and obesity-specific survey were evaluated in one study.
Moderate evidence was found for good internal
consistency and reliability (32). There was moderate
evidence for indeterminate content validity and structural
validity (32). The evidence of hypotheses testing remains
unknown because of poor methodological quality of the
study (32).
Quality of Life for Obesity Surgery (bariatric
surgery). The measurement properties of the Quality of
Life for Obesity Surgery were evaluated in one study.
There was strong evidence for good content validity,
moderate evidence for good internal consistency and
structural validity and limited evidence for indeterminate
hypotheses testing (41).
Norwegian Obesity-related Problems scale (bariatric
surgery). The measurement properties of the Norwegian
OP-scale were evaluated in one study. Moderate evidence
was found for good internal consistency and structural
validity, and limited evidence was found for good
hypotheses testing and responsiveness (45). The evidence
for cross-cultural validity remains unknown because of
poor methodological quality of the study (45).
Interpretability yielded a mean absolute change of 42.29
(45).
Spanish Obesity-related Problems scale (bariatric
surgery). The measurement properties of the Spanish
OP-scale were evaluated in one study. Moderate evidenceTa
b
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was found for good internal consistency and structural
validity, and limited evidence was found for good
hypotheses testing (47). The evidence for cross-cultural
validity remains unknown because of poor methodological
quality of the study (47).
Danish BODY-Q (bariatric surgery and body
contouring surgery). Two studies evaluated the
measurement properties of the Danish BODY-Q. There
was strong evidence for good content validity, moderate
evidence for good cross-cultural validity and limited
evidence for good internal consistency and structural
validity (43,44).
Category C instruments
Two instruments (BS) had poor quality in at least one re-
quired quality criterion and were not recommended to be
used in BS (category C). The BQL-Index (34,35) and the La-
val Questionnaire (33) had low quality in one measurement
property. Structural validity was poor for the BQL-Index
(34), and conflicting evidence was found for responsiveness
of the Laval Questionnaire (33).
Category D instruments
Fifteen instruments (BS) were minimally validated and are
not recommended for use until adequate validation studies
clarify their quality. These included Moorehead-Ardelt
Quality of Life Questionnaire (M-A QoLQ)/Bariatric Anal-
ysis and Reporting Outcome System (31), GIQLI (36),
Impact of Weight Quality of Life-Lite (IWQoL-Lite) (37),
M-A QoLQII (38), Post Bariatric Outcome Tool (39), OP-
scale (40), EQ-5D-5L (42), Greek, Korean, Portuguese,
Czech, German, Italian and Spanish M-A QoLQII (48–51)
and Spanish IWQoL-lite (46). The evidence of the majority
of the measurement properties of these instruments could
not be interpreted due to poor methodological quality of
the study. The OP-scale showed moderate evidence for good
internal consistency and structural validity (40), and the
Spanish IWQoL-lite showed moderate evidence for good in-
ternal consistency and limited evidence for good structural
validity (46). Limited evidence was found for good reliabil-
ity of the Greek and Portuguese M-A QoLQII (48,50). Con-
flicting evidence was found for hypotheses testing of the
EQ-5D-5L (42).
Discussion
This systematic review evaluated and compared the mea-
surement properties of 21 QoL instruments designed for
use in BS, one QoL instrument designed for use in BCS
and two QoL instruments designed for use in both BS and
BCS. None of these instruments complied with the filter re-
quirements of truth, discrimination and feasibility, whichTa
b
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indicates the need for further validation studies. Hence, no
QoL instrument can currently be highly recommended. All
identified instruments have gaps in their validation, and
none of the instruments provided evidence of the quality
of measurement error or estimated a minimally important
difference. Remarkably, criterion validity was still described
as a measurement property in some validation studies, even
though no true gold standard is available in QoL measures.
Further work is needed to validate the available tools for BS
and BCS, and this should be a priority.
The most frequently used instruments in BS, such as the
M-A QoLQ (Bariatric Analysis and Reporting Outcome
System), the GIQLI, M-A QoLQII, EQ-5D and the
IWQoL-Lite, lack adequate and methodologically good val-
idation data (12,52). Their methodological quality was
mostly poor across all measurement properties. The GIQLI
lacks domains relevant to BS and BCS in particular. Ade-
quate validation studies are needed to clarify the quality of
these instruments before they can be recommended for use
in clinical trials and prospective studies. Of the QoL instru-
ments placed in category B, this review suggests that the
BODY-Q has the most potential to be recommended in the
future depending on the results of further validation studies.
The BODY-Q intended for use in both BS and BCS was sup-
ported by positive evidence of internal consistency, reliabil-
ity and adequate structural validity. Compared with the
other instruments, the BODY-Q is unique in the application
of a modern psychometric approach, Rasch Measurement
Theory (RMT) analysis, in the development of the measure-
ment instruments. RMT analysis provides more sophisti-
cated information than the traditional approach, the
classical test theory, and offers a major contribution to the
concept of reliability. In the classical test theory approach,
scale (IWQOL-Lite) or item (M-A QoLQ) scores can be
added to create a total score for a measurement instrument.
There is no evidence, however, that the summed total scores
allow for meaningful interpretation of scores (53,54). This
approach limits its information to identify whether or not
treatment effects are influenced by some scales or items
and not others (53,54). Most importantly, the BODY-Q
showed excellent content validity, as the development of
the items of the BODY-Q was based on a literature review,
patient interviews, cognitive patient interviews and input
from experts. The BODY-Q is useful for the target popula-
tion (BS and BCS), particularly with the growing field of
BCS in mind. A disadvantage of the BODY-Q is that not
many translations are already available and the long com-
pletion time of 138 items. Nevertheless, the RMT approach
provides the opportunity for Computer Adaptive Testing,
which can reduce the length of the measurement instrument.
Further validation studies of the BODY-Q should focus on
measurement error, construct validity and interpretability.
This is the first systematic review to make recommenda-
tions based on quality standards and criteria; previous
systematic reviews reported only on measurement proper-
ties (11–14). The COSMIN checklist, the levels of evidence
and the four degrees of recommendations were used as qual-
ity standards and criteria. We applied two sensitive and val-
idated search filters and used predefined eligibility criteria to
identify all PROMs in BS and BCS. In the present study, we
were as inclusive as possible to give a comprehensive over-
view of all PROMs in BS and BCS (e.g. we included the
IWQoL-Lite in our review, even though the measurement
properties were only described in a systematic review). On
the other hand, we were strict in excluding PROMs vali-
dated solely in patients with obesity – not BS or BCS – such
as the Obesity and Weight-Loss Quality of Life and the
Weight-Related Symptoms measures. We gathered informa-
tion on interpretability and generalizability. At least two re-
viewers performed all steps in our systematic review with
frequent discussions to resolve conflicts.
We have used the COSMIN checklist, published in 2010,
to evaluate the methodological quality of the studies. Some
of the PROMs may be of higher quality than indicated by
the COSMIN checklist simply because the studies were per-
formed longer ago and measurement properties were not re-
ported. Almost all instruments developed after publication
of the COSMIN checklist performed best, which could be
due to more strict standards on how to perform studies on
measurement properties. Only the Post Bariatric Outcome
Table 9 Category of recommendations
Category of recommendation
instruments
A –
B Body-QoL, BODY-Q, BOSS, QOLOS, Danish BODY-Q, Norwegian and Spanish OP-scale
C BQL-Index, Laval questionnaire
D M-A QoLQ/BAROS, GIQLI, IWQoL-Lite, M-A QoLQII, PBOT, OP-scale, EQ-5D-5L, Greek, Korean, Portuguese,
Czech, German, Italian and Spanish M-A QoLQII
BAROS, Bariatric Analysis and Reporting Outcome System; Body-QoL, Body-Shape-Related Quality of Life; BOSS, bariatric and obesity-specific survey;
BQL Index, Bariatric Quality of Life Index; GIQLI, Gastrointestinal Quality of Life Index; IWQOL-Lite, Impact of Weight Quality of Life-Lite; M-A QoLQ,
Moorehead-Ardelt Quality of Life Questionnaire; M-A QoLQII, Moorehead-Ardelt Quality of Life Questionnaire II; OP-scale, Obesity-related Problems scale;
PBOT, Post Bariatric Outcome Tool; QOLOS, Quality of Life for Obesity Surgery.
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Tool (developed in 2014) is minimally validated; however,
they described in their discussion some measurement prop-
erties that still have to be evaluated in further validation
studies. Furthermore, the most important components for
QoL in BS and BCS have yet to be established internation-
ally and therefore could not be integrated into our recom-
mendations. Additionally, in the COSMIN checklist, the
benchmark for missing data is weighted in almost all mea-
surement properties. Studies that did not clearly report
how missing data were handled were rated as ‘fair’. We felt
this would outweigh the overall quality of the studies, and,
although we strongly recommend developers to report on
missing data, we therefore decided to deviate from this guid-
ance. We rated the overall quality of the study as good, if
only the item ‘description of how missing items were han-
dled’ was rated as inadequate.
In this systematic review, we identified validation evi-
dence for PROMs used in BS and BCS and evaluated the
methodological quality of all outcome measure validity
studies using the COSMIN checklist. The final step of how
QoL should be measured is the development of an
evidence-based consensus over the preferred PROMs for
measuring QoL in BS and BCS. We propose an international
and multi-professional consensus meeting to define generic
recommendations on the selection of PROMs for QoL in
BS and BCS. We aim to achieve global consensus over the
key components of QoL and the preferred PROMs to cap-
ture this information. The consensus meeting will produce
guidelines for researchers undertaking BS and BCS research
and for clinicians considering incorporation of QoL assess-
ment in the evaluation of treatments for severe and complex
obesity. A secondary goal is to stimulate further discussion
and research ideas in the interpretation of QoL assessment
in BS and BCS.
Improving the consistency of reporting QoL will reduce
heterogeneity between trials and outcome reporting bias,
which will improve the quality of data to undertake meta-
analyses and inform clinical decision-making. Additionally,
it may not be feasible for individual clinical trials to perform
all steps in the selection of PROMs. This underlines the im-
portance of worldwide consensus on the selection of
PROMs for QoL in bariatric and metabolic surgery.
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